SCHEMBL4601679

SCHEMBL4601679

CCCOc1ccc(-c2ccc(F)cc2)cc1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 5/20 0.64
PTPN1 P18031 1/20 0.60
PTPN6 P29350 1/20 0.60
CFD P00746 1/20 0.49
RARA P10276 1/20 0.48
RARB P10826 1/20 0.48
S1PR3 Q99500 1/20 0.47
METTL3 Q86U44 3/20 0.47
METTL14 Q9HCE5 3/20 0.47
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
HPSE Q9Y251 1/20 0.45
PPARG P37231 1/20 0.44
LTB4R Q15722 3/20 0.44
LTB4R2 Q9NPC1 3/20 0.44
ADRB1 P08588 1/20 0.44
ADRB3 P13945 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4601640 0.90 PTPN11 (0.59) PTPN11PTPN1PTPN6CFDRARA
SCHEMBL15630531 0.89 ADRB1 (0.55) PTPN11PTPN1PTPN6RARARARB
SCHEMBL4600863 0.88 PTPN11 (0.56) PTPN11PTPN1PTPN6CFDRARA
SCHEMBL4601658 0.88 PTPN11 (0.67) PTPN11PTPN1PTPN6CFDS1PR3
SCHEMBL7959141 0.88 PTPN11 (0.51) PTPN11PTPN1PTPN6S1PR3ALDH1A1
SCHEMBL4602266 0.88 PTPN11 (0.64) PTPN11PTPN1PTPN6CFDRARA
SCHEMBL4601436 0.87 PTPN11 (0.59) PTPN11PTPN1PTPN6CFDRARA
SCHEMBL14610852 0.87 PTPN11 (0.49) PTPN11PTPN1PTPN6ALDH1A1MAPT
SCHEMBL4603016 0.87 PTPN11 (0.82) PTPN11PTPN1PTPN6CFDRARA
SCHEMBL4602854 0.86 PTPN11 (0.57) PTPN11PTPN1PTPN6CFDRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R PTPN11 3529/4885PTPN1 3489/4885PTPN6 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.